Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8765 |
High Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.8683 |
High Similarity |
NPD8313 |
Approved |
0.8683 |
High Similarity |
NPD8312 |
Approved |
0.8421 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.8343 |
Intermediate Similarity |
NPD6534 |
Approved |
0.8343 |
Intermediate Similarity |
NPD6535 |
Approved |
0.8278 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.8232 |
Intermediate Similarity |
NPD8320 |
Phase 1 |
0.8232 |
Intermediate Similarity |
NPD8319 |
Approved |
0.8212 |
Intermediate Similarity |
NPD6776 |
Approved |
0.8212 |
Intermediate Similarity |
NPD6779 |
Approved |
0.8212 |
Intermediate Similarity |
NPD6778 |
Approved |
0.8212 |
Intermediate Similarity |
NPD6781 |
Approved |
0.8212 |
Intermediate Similarity |
NPD6782 |
Approved |
0.8212 |
Intermediate Similarity |
NPD6780 |
Approved |
0.8212 |
Intermediate Similarity |
NPD6777 |
Approved |
0.8202 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.8202 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.8182 |
Intermediate Similarity |
NPD6213 |
Phase 3 |
0.8182 |
Intermediate Similarity |
NPD6214 |
Clinical (unspecified phase) |
0.8182 |
Intermediate Similarity |
NPD6212 |
Phase 3 |
0.8171 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8129 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.8114 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.8084 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8075 |
Intermediate Similarity |
NPD3226 |
Approved |
0.8059 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8047 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8025 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.8012 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.8011 |
Intermediate Similarity |
NPD7874 |
Approved |
0.8011 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.7978 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7978 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7978 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7977 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7953 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7935 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7935 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7923 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.7917 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7907 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7903 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.7895 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7879 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7872 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.7872 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7861 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7861 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7849 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7844 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7834 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7816 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7778 |
Intermediate Similarity |
NPD7801 |
Approved |
0.7771 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7771 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7771 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7771 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7771 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7771 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7764 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7744 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.774 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7722 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7716 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7716 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7716 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7716 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7707 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7701 |
Intermediate Similarity |
NPD7211 |
Clinical (unspecified phase) |
0.7688 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7682 |
Intermediate Similarity |
NPD1470 |
Approved |
0.7679 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7674 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7674 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7674 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7665 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7665 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7651 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7651 |
Intermediate Similarity |
NPD1201 |
Approved |
0.764 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7636 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7619 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7619 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7614 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7605 |
Intermediate Similarity |
NPD37 |
Approved |
0.7605 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7605 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7602 |
Intermediate Similarity |
NPD8155 |
Clinical (unspecified phase) |
0.7588 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7586 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7578 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7574 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7574 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7574 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7558 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7486 |
Intermediate Similarity |
NPD7799 |
Discontinued |
0.7484 |
Intermediate Similarity |
NPD5952 |
Clinical (unspecified phase) |
0.7471 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7438 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7436 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7427 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7412 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.741 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7407 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7394 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7394 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7381 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7362 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.736 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7353 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7346 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7341 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7333 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7318 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7308 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7299 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7296 |
Intermediate Similarity |
NPD7930 |
Approved |
0.7289 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7284 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7284 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7273 |
Intermediate Similarity |
NPD3300 |
Phase 2 |
0.7267 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7257 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7257 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7251 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7241 |
Intermediate Similarity |
NPD8058 |
Clinical (unspecified phase) |
0.7241 |
Intermediate Similarity |
NPD8059 |
Phase 3 |
0.7239 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7229 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7215 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7202 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7196 |
Intermediate Similarity |
NPD8285 |
Discontinued |
0.7195 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7191 |
Intermediate Similarity |
NPD7177 |
Discontinued |
0.7171 |
Intermediate Similarity |
NPD5126 |
Approved |
0.7171 |
Intermediate Similarity |
NPD5125 |
Phase 3 |
0.7168 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.716 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.716 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.716 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7152 |
Intermediate Similarity |
NPD8166 |
Discontinued |
0.7152 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7152 |
Intermediate Similarity |
NPD7003 |
Approved |
0.715 |
Intermediate Similarity |
NPD7999 |
Approved |
0.7143 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7126 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7125 |
Intermediate Similarity |
NPD943 |
Approved |
0.7125 |
Intermediate Similarity |
NPD7966 |
Clinical (unspecified phase) |
0.7119 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7117 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7113 |
Intermediate Similarity |
NPD7584 |
Approved |
0.7081 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.707 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7048 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7043 |
Intermediate Similarity |
NPD8360 |
Approved |
0.7043 |
Intermediate Similarity |
NPD8361 |
Approved |
0.7041 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7041 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7033 |
Intermediate Similarity |
NPD8368 |
Discontinued |
0.7019 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7012 |
Intermediate Similarity |
NPD2438 |
Suspended |
0.7012 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7012 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7012 |
Intermediate Similarity |
NPD6100 |
Approved |
0.6995 |
Remote Similarity |
NPD4955 |
Approved |
0.6995 |
Remote Similarity |
NPD5028 |
Approved |
0.6995 |
Remote Similarity |
NPD5026 |
Approved |
0.6995 |
Remote Similarity |
NPD36 |
Approved |
0.6995 |
Remote Similarity |
NPD4954 |
Approved |
0.6995 |
Remote Similarity |
NPD5034 |
Approved |
0.6994 |
Remote Similarity |
NPD4978 |
Clinical (unspecified phase) |
0.6975 |
Remote Similarity |
NPD1933 |
Approved |
0.6964 |
Remote Similarity |
NPD7236 |
Approved |
0.6961 |
Remote Similarity |
NPD8470 |
Clinical (unspecified phase) |
0.6959 |
Remote Similarity |
NPD7239 |
Suspended |
0.6952 |
Remote Similarity |
NPD8435 |
Approved |
0.6951 |
Remote Similarity |
NPD651 |
Clinical (unspecified phase) |
0.694 |
Remote Similarity |
NPD5030 |
Phase 2 |
0.6937 |
Remote Similarity |
NPD7008 |
Discontinued |
0.6935 |
Remote Similarity |
NPD5038 |
Approved |
0.6935 |
Remote Similarity |
NPD5037 |
Approved |
0.6928 |
Remote Similarity |
NPD9545 |
Approved |
0.6927 |
Remote Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.6919 |
Remote Similarity |
NPD8407 |
Phase 2 |
0.6914 |
Remote Similarity |
NPD4060 |
Phase 1 |
0.6911 |
Remote Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.6908 |
Remote Similarity |
NPD405 |
Clinical (unspecified phase) |
0.6908 |
Remote Similarity |
NPD9493 |
Approved |
0.6904 |
Remote Similarity |
NPD7585 |
Approved |
0.6899 |
Remote Similarity |
NPD1164 |
Approved |
0.6894 |
Remote Similarity |
NPD1699 |
Clinical (unspecified phase) |
0.689 |
Remote Similarity |
NPD7097 |
Phase 1 |
0.6886 |
Remote Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.6885 |
Remote Similarity |
NPD5953 |
Discontinued |
0.6882 |
Remote Similarity |
NPD8389 |
Clinical (unspecified phase) |
0.6882 |
Remote Similarity |
NPD5036 |
Approved |
0.6875 |
Remote Similarity |
NPD6832 |
Phase 2 |
0.6872
|
Remote Similarity |
NPD7680 |
Approved |